» Articles » PMID: 31504712

'More Than Devastating'-patient Experiences and Neurological Sequelae of Japanese Encephalitis§

Overview
Journal J Travel Med
Date 2019 Sep 11
PMID 31504712
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Japanese encephalitis (JE), caused by the mosquito-borne JE virus, is a vaccine-preventable disease endemic to much of Asia. Travellers from non-endemic areas are susceptible if they travel to a JE endemic area. Although the risk to travellers of JE is low, the consequences may be severe.

Methods: Here, we describe three cases of JE in British travellers occurring in 2014-15. In addition, we report, through interviews with survivors and their families, personal experiences of life after JE.

Results: Three cases of JE were diagnosed in British travellers in 2014/15. One was acquired in Thailand, one in China and one in either Thailand, Laos or Cambodia. All three patients suffered severe, life-threatening illnesses, all were admitted to intensive care units and required medical evacuation back to the UK. One patient suffered a cardiac arrest during the acute stage but made a good recovery. The other two patients remain significantly paralysed and ventilator dependent. All three cases had clear indications for vaccination, and all have been left with life-changing neurological sequelae.

Conclusions: Travel health providers should be aware of the severity of JE, as well as the risk, allowing travellers to make fully informed decisions on JE vaccination.

Citing Articles

Flaviviruses-Induced Neurological Sequelae.

Cody S, Adam A, Siniavin A, Kang S, Wang T Pathogens. 2025; 14(1).

PMID: 39860983 PMC: 11768111. DOI: 10.3390/pathogens14010022.


A scoping review of evidence of naturally occurring Japanese encephalitis infection in vertebrate animals other than humans, ardeid birds and pigs.

Levesque Z, Walsh M, Webb C, Zadoks R, Brookes V PLoS Negl Trop Dis. 2024; 18(10):e0012510.

PMID: 39365832 PMC: 11482687. DOI: 10.1371/journal.pntd.0012510.


In Vitro Antiviral Activity of Extract against Zika Virus and Japanese Encephalitis Virus: Viral Binding and Stability.

Lai Z, Yen I, Hung H, Hong C, Lai C, Lee Y Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204093 PMC: 11357342. DOI: 10.3390/ph17080988.


Mice as an Animal Model for Japanese Encephalitis Virus Research: Mouse Susceptibility, Infection Route, and Viral Pathogenesis.

Frank J, Song B, Lee Y Pathogens. 2023; 12(5).

PMID: 37242385 PMC: 10222868. DOI: 10.3390/pathogens12050715.


Japanese Encephalitis among Adults: A Review.

Hills S, Netravathi M, Solomon T Am J Trop Med Hyg. 2023; 108(5):860-864.

PMID: 37037440 PMC: 10160886. DOI: 10.4269/ajtmh.23-0036.


References
1.
Hatz C, Werlein J, Mutsch M, Hufnagel M, Behrens R . Japanese encephalitis: defining risk incidence for travelers to endemic countries and vaccine prescribing from the UK and Switzerland. J Travel Med. 2009; 16(3):200-3. DOI: 10.1111/j.1708-8305.2009.00334.x. View

2.
Turtle L, Driver C . Risk assessment for Japanese encephalitis vaccination. Hum Vaccin Immunother. 2017; 14(1):213-217. PMC: 5791557. DOI: 10.1080/21645515.2017.1380756. View

3.
Gao X, Li X, Li M, Fu S, Wang H, Lu Z . Vaccine strategies for the control and prevention of Japanese encephalitis in Mainland China, 1951-2011. PLoS Negl Trop Dis. 2014; 8(8):e3015. PMC: 4133196. DOI: 10.1371/journal.pntd.0003015. View

4.
Leder K, Torresi J, Libman M, Cramer J, Castelli F, Schlagenhauf P . GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med. 2013; 158(6):456-68. PMC: 4629801. DOI: 10.7326/0003-4819-158-6-201303190-00005. View

5.
Burdon J, Stanley P, Lloyd G, Jones N . A case of Japanese encephalitis. J Infect. 1994; 28(2):175-9. DOI: 10.1016/s0163-4453(94)95640-5. View